<DOC>
	<DOCNO>NCT00195351</DOCNO>
	<brief_summary>This phase 3b/4 randomize , open-label , comparative , multicenter study safety efficacy tigecycline ceftriaxone sodium plus metronidazole hospitalized subject cIAI ( Complicated Intra-Abdominal Infection ) . Subjects clinical sign symptom cIAI include enrollment . Subjects stratify randomization Acute Physiologic Chronic Health Evaluation scale ( APACHE II ) score &lt; 10 &gt; 10 . Subjects follow efficacy test-of-cure assessment . Safety evaluation occur treatment post-treatment period continue resolution stability adverse event ( ) .</brief_summary>
	<brief_title>Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole Complicated Intra-abdominal Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Appendicitis</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Clinical diagnosis complicate intraabdominal infection require surgery within 24 hour . Fever 100.4°F ( 38.0°C ) high white blood cell count plus symptom nausea , vomit , abdominal pain . Cancer Medicines suppress immune system Dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Complicated intra-abdominal infection</keyword>
	<keyword>Appendicitis abscess</keyword>
	<keyword>Perforated diverticulitis</keyword>
	<keyword>Purulent peritonitis</keyword>
	<keyword>Complicated cholecystitis</keyword>
</DOC>